BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38516767)

  • 1. Targeted degradation of hexokinase 2 for anti‑inflammatory treatment in acute lung injury.
    Yang J; Dong L; Wang Y; Gong L; Gao H; Xie Y
    Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38516767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunometabolic reprogramming of macrophages with inhalable CRISPR/Cas9 nanotherapeutics for acute lung injury intervention.
    Huang W; Fu G; Wang Y; Chen C; Luo Y; Yan Q; Liu Y; Mao C
    Acta Biomater; 2024 Jun; 181():308-316. PubMed ID: 38570107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysimachia clethroides Duby extract attenuates inflammatory response in Raw 264.7 macrophages stimulated with lipopolysaccharide and in acute lung injury mouse model.
    Shim DW; Han JW; Sun X; Jang CH; Koppula S; Kim TJ; Kang TB; Lee KH
    J Ethnopharmacol; 2013 Dec; 150(3):1007-15. PubMed ID: 24145006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model.
    Zhong WJ; Yang HH; Guan XX; Xiong JB; Sun CC; Zhang CY; Luo XQ; Zhang YF; Zhang J; Duan JX; Zhou Y; Guan CX
    J Cell Physiol; 2019 Apr; 234(4):4641-4654. PubMed ID: 30256406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑26a‑5p alleviates lipopolysaccharide‑induced acute lung injury by targeting the connective tissue growth factor.
    Li H; Yang T; Fei Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti‑inflammatory effects of Panax notoginseng saponins ameliorate acute lung injury induced by oleic acid and lipopolysaccharide in rats.
    Chen YQ; Rong L; Qiao JO
    Mol Med Rep; 2014 Sep; 10(3):1400-8. PubMed ID: 24938646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginkgolide C attenuates lipopolysaccharide‑induced acute lung injury by inhibiting inflammation via regulating the CD40/NF‑κB signaling pathway.
    Zhang R; Guo N; Yan G; Wang Q; Gao T; Zhang B; Hou N
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size-dependent anti-inflammatory activity of a peptide-gold nanoparticle hybrid in vitro and in a mouse model of acute lung injury.
    Gao W; Wang Y; Xiong Y; Sun L; Wang L; Wang K; Lu HY; Bao A; Turvey SE; Li Q; Yang H
    Acta Biomater; 2019 Feb; 85():203-217. PubMed ID: 30597258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression level of 12-amino acid triggering receptor on myeloid cells-like transcript 1 derived peptide alleviates lipopolysaccharide-induced acute lung injury in mice.
    Shi R; Zhang J; Peng Z; Yuan S; Gao S; Chen L; Yuan Y
    Int J Mol Med; 2018 Apr; 41(4):2159-2168. PubMed ID: 29393375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA‑17 contributes to the suppression of the inflammatory response in lipopolysaccharide‑induced acute lung injury in mice via targeting the toll‑like receptor 4/nuclear factor‑κB pathway.
    Fu S
    Int J Mol Med; 2020 Jul; 46(1):131-140. PubMed ID: 32626914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner.
    Huang XT; Liu W; Zhou Y; Hao CX; Zhou Y; Zhang CY; Sun CC; Luo ZQ; Tang SY
    Int J Mol Med; 2019 Dec; 44(6):2213-2222. PubMed ID: 31661121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIM1 inhibitor SMI-4a attenuated lipopolysaccharide-induced acute lung injury through suppressing macrophage inflammatory responses via modulating p65 phosphorylation.
    Wang J; Cao Y; Liu Y; Zhang X; Ji F; Li J; Zou Y
    Int Immunopharmacol; 2019 Aug; 73():568-574. PubMed ID: 31203114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexmedetomidine alleviates LPS‑induced acute lung injury via regulation of the p38/HO‑1 pathway.
    Sun Y; Xia Y; Liu X; Liu J; He W; Ye H; Yuan X
    Mol Med Rep; 2020 Sep; 22(3):2442-2450. PubMed ID: 32705282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trametinib alleviates lipopolysaccharide-induced acute lung injury by inhibiting the MEK-ERK-Egr-1 pathway.
    Chen S; Xu H; Ye P; Wu C; Ding X; Chen S; Zhang H; Zou Y; Zhao J; Le S; Wu J; Chen S; Xia J
    Int Immunopharmacol; 2020 Mar; 80():106152. PubMed ID: 31926447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chalcone derivative, L2H17, ameliorates lipopolysaccharide-induced acute lung injury via upregulating HO-1 activity.
    Lin Y; Qiu D; Huang L; Zhang S; Song C; Wang B; Wu J; Chen C
    Int Immunopharmacol; 2019 Jun; 71():100-108. PubMed ID: 30884345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
    Luo Y; Che W; Zhao M
    Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone releasing peptide-2, a ghrelin agonist, attenuates lipopolysaccharide-induced acute lung injury in rats.
    Li G; Li J; Zhou Q; Song X; Liang H; Huang L
    Tohoku J Exp Med; 2010 Sep; 222(1):7-13. PubMed ID: 20805679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
    Qiushi W; Guanghua L; Guangquan X
    Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effect of stem bark of Paulownia tomentosa Steud. in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages and LPS-induced murine model of acute lung injury.
    Lee JW; Seo KH; Ryu HW; Yuk HJ; Park HA; Lim Y; Ahn KS; Oh SR
    J Ethnopharmacol; 2018 Jan; 210():23-30. PubMed ID: 28843892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg1 improves lipopolysaccharide-induced acute lung injury by inhibiting inflammatory responses and modulating infiltration of M2 macrophages.
    Bao S; Zou Y; Wang B; Li Y; Zhu J; Luo Y; Li J
    Int Immunopharmacol; 2015 Sep; 28(1):429-34. PubMed ID: 26122136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.